Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Inclusion Criteria

• •Subject is 18 years of age or older;
• •Subject is willing to provide written informed consent;
• •Subject has a diagnosis of a non-hematologic cancer, has tumor in the body, and has either;
• •1. residual tumor tissue available for testing by the Sponsor; or
• •2. genomic profiling results from an IVD or LDT assay performed on tumor biopsy tissue; or
• •3. an invasive procedure (biopsy, surgery) scheduled following the Baseline Visit from which residual tumor tissue can be available for testing by the Sponsor.
• •Subject is able, in the professional opinion of the investigator, to provide whole blood at the Baseline Visit and at the Interim Visits.